ClinicalTrialsFinder

Recurrent and Refractory Diffuse Large B-cell Lymphoma Clinical Trials in Chengdu, Sichuan

1 recruitingChengdu, Sichuan, China

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma

Recurrent and Refractory Diffuse Large B-cell Lymphoma
Chengdu Zenitar Biomedical Technology Co., Ltd390 enrolled1 locationNCT07011056